CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions
Nov 8, 2017
1 min read
Updated: Dec 10, 2021
This memo outlines some of the challenges and benefits of ARV optimization, highlighting product transition successes through country-case studies.




Comments